Peel Hunt Reiterates Hold Rating for ConvaTec Group (CTEC)
A number of other equities analysts have also issued reports on CTEC. Numis Securities upgraded ConvaTec Group to a reduce rating and set a GBX 180 ($2.49) target price for the company in a research note on Wednesday, October 18th. Deutsche Bank restated a sell rating and issued a GBX 180 ($2.49) target price on shares of ConvaTec Group in a research note on Friday, December 1st. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company’s stock. The stock presently has a consensus rating of Hold and an average target price of GBX 244.67 ($3.38).
ConvaTec Group (LON CTEC) opened at GBX 215.30 ($2.97) on Thursday. The stock has a market capitalization of $4,200.00 and a price-to-earnings ratio of 3,588.33. ConvaTec Group has a 52 week low of GBX 181.40 ($2.51) and a 52 week high of GBX 349.10 ($4.82).
In related news, insider Ros Rivaz acquired 4,821 shares of ConvaTec Group stock in a transaction on Wednesday, December 6th. The stock was acquired at an average price of GBX 206 ($2.85) per share, for a total transaction of £9,931.26 ($13,721.00).
TRADEMARK VIOLATION WARNING: This news story was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright laws. The legal version of this news story can be accessed at https://www.thecerbatgem.com/2018/02/19/peel-hunt-reiterates-hold-rating-for-convatec-group-ctec.html.
ConvaTec Group Company Profile
ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.